𝔖 Bobbio Scriptorium
✦   LIBER   ✦

5-aminosalicylates in inflammatory bowel disease and chronic renal failure: Authors' reply

✍ Scribed by A. F. Muller; P. E. Stevens; A. S. McIntyre; H. Ellison; R. F. Logan


Book ID
108604226
Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
48 KB
Volume
22
Category
Article
ISSN
0269-2813

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


5-Aminosalicylates and renal function in
✍ Javier P. Gisbert; Yago GonzΓ‘lez-Lama; JosΓ© MatΓ© πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 114 KB πŸ‘ 2 views

Nephrotoxicity has been described in some patients with inflammatory bowel disease (IBD) treated with 5-aminosalicylic acid (5-ASA). Studies with 5-ASA treatment in which serum creatinine or creatinine clearance was measured regularly show that nephrotoxicity is exceptional (mean rate of only 0.26%